The molecular profile of Chinese CMML patients displayed a wide range of mutations, and the emerging genes such as DNMT3A, ETV6, FLT3, and NPM1 usually indicated a dismal outcome of disease progression. This evidence concerns the gene DNMT3A and chronic myelomonocytic leukemia.